← Back to Clinical Trials
Recruiting NCT02253251
NCT02253251 Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Treatment
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT02253251 |
| Status | Recruiting |
| Phase | — |
| Sponsor | MiraKind |
| Condition | Cancer |
| Study Type | OBSERVATIONAL |
| Enrollment | 15,000 participants |
| Start Date | 2014-09 |
| Primary Completion | 2030-12 |
Trial Parameters
Condition Cancer
Sponsor MiraKind
Study Type OBSERVATIONAL
Phase N/A
Enrollment 15,000
Sex ALL
Min Age 18 Years
Max Age N/A
Start Date 2014-09
Completion 2030-12
Interventions
KRAS-variant and microRNA binding site mutation testing
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The investigators will recruit and enroll individuals that may have the KRAS-variant or other microRNA binding site mutations to join registry studies. The investigators will allow individuals to obtain their results through a physician at the completion of the studies. The investigators current focus is cancer and autoimmunity.
Eligibility Criteria
Inclusion Criteria: * Personal or family history of cancer * Personal history of endometriosis, or autoimmunity Exclusion Criteria: * Younger than 18 * Non-english speaking and unable to understand and sign the consent
Related Trials
NCT06760754
Examining the Feasibility and Impact of a Clinic-based Food Farmacy and Digital Culinary Medicine Pr
View Trial →
NCT05474846
Combination Therapy for Treatment of Sleep Disturbance in Patients With Advanced Cancer
View Trial →
NCT02253251
Clinical Validation of the Role of microRNA Binding Site Mutations in Cancer Risk, Prevention and Tr
View Trial →
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology